Bamf Health, Inc

Grand Rapids, Michigan 49503

4 studies enrolling now · 8 studies all time

What they study most

Biochemical Recurrence of Malignant Neoplasm of Prostate, Breast Neoplasms, Castration-Resistant, Castration-Resistant Prostatic Cancer, Cholangiocarcinoma, Cholesterol, Colorectal Cancer, Colorectal Neoplasms, Endometrial Neoplasms, Esophageal Cancer, Esophageal Neoplasms, Gastric Cancer

Studies at this site

• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — Recruiting now
• A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer — Recruiting now
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — Recruiting now
• Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4) — Recruiting now
• 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer — Recruiting now
• 64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) — Completed
• 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) — Stopped early
• Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — TEMPORARILY_NOT_AVAILABLE